(HealthDay News) — People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems compared with patients treated with glucagon-like peptide-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback